Direct Flow Medical takes $40M for heart valve treatments
Direct Flow Medical, maker of a minimally-invasive device to treat heart valve disease, has raised $40 million of a targeted $42.5 million third round of venture funding, according to a filing with the SEC. Based in Santa Rosa, Calif., the company is backed by Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners. It has raised $75 million to date.
Life sciences briefing: Friday, Oct. 19, 2007
Featured companies: DirectFlow, Direvo, Indigo Biosystems, MacroGenics
Direct Flow raises $27M for heart-valve implants — Santa Rosa, Calif.-based Direct Flow Medical, a startup developing heart implants, raised $27 million in a second funding round. Investors included Johnson & Johnson Development, Foundation Medical Partners, VantagePoint Venture Partners, ePlanet, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.
Direct Flow makes minimally invasive aortic-valve replacements for the heart. This particular field happens to be booming — we’ve previously covered… Continue Reading